Bioceres Crop Solutions Corp. · NASDAQ:BIOX
Bioceres Crop Solutions — Morgan Stanley Investor Conference 2020
13 slides from Bioceres Crop Solutions's conference presentation, Nov 11, 2020
Slide 1: Morgan Stanley Investor Conference
Morgan Stanley Investor Conference Virtual Event November 2020
Slide 2: Disclaimer and Forward-looking Statement
Disclaimer and Forward-looking Statement This Presentation is for informational purposes only and does not constitute an offer or invitation to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, assets, business, debt or other financial instruments of the Company or
Slide 3: Overview
Overview We are a fully-integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality A Compelling Biotech story By the Numbers Addressing global agriculture challenges through a carbon neutral approach $ 174.2M $ 46.5M Revenues1 Adj
Slide 4: Business Segments and Product Portfolio
Business Segments and Product Portfolio Leading positions and multiple growth levers Segment Crop Protection Crop Nutrition Seed & Integrated Products Increase Full range of pest Nitrogen-fixing Micro-beaded Full seed treatment EcoSoy and effectiveness and control molecules biologicals t
Slide 5: The HB4® Technology Performance
The HB4® Technology Performance Bioceres’ proprietary HB4® technology is the only available technology for drought tolerance in soybean-wheat cropping systems EcoSoy EcoWheat CONTROL CONTROL Drought & Salinity tolerance Drought & Salinity tolerance +13% impact in yields +19.5% impact in yields Confi
Slide 6: HB4® Value Creation to Farmers
HB4® Value Creation to Farmers 34 Mha 29 Mha 20 Mha Additional crop value created by HB4® 160 $/ha 55 $/ha Combination of EcoWheat and EcoSoy for Argentina. Brazil and US, EcoSoy only Confidential Information 6
Slide 7: HB4® Regulatory Approvals
HB4® Regulatory Approvals Regulatory approval in over 80% of the global soybean market (AR, BR and US), and pending approvals in 6 other countries Regulatory approval obtained Approval requested Confidential Information 7
Slide 8: HB4® and the EcoSeed Concept
HB4® and the EcoSeed Concept Isolated and characterized microbial Integration of strains into HB4 varieties Integrated/customized strains that promote growth for and other biological assets, to create seed product with data different environments non-replicable seed products interface Confidential I
Slide 9: The HB4® Program
The HB4® Program The HB4® Program is an identity preserved production system for soybean and wheat. The Program establishes good agricultural practices for growers, which enhanced by our technologies, significantly contribute to the transition of agriculture towards carbon neutrality Certified Susta
Slide 10: Company Performance
Company Performance Proven track-record in delivering solid financial performance Revenues ($M) Adjusted EBITDA ($M) 173 161 41 47 134 87 22 14 FY17 FY18 FY19 FY20 FY17 FY18 FY19 FY20 1. Financials presented correspond to As Reported financials for FY2020 (ended June 30th, 2020) Confidential Informa
Slide 11: Financial Debt Position
Financial Debt Position Strengthened Balance Sheet and Increased Liquidity Net Debt 2.24x 2.14x 2.23x 2..30x 1.96x LTM EBITDA $ million 79.6 84.3 93.5 91.3 92.8 92.1 86.8 40.1 37.1 32.5 52.6 56.6 63.5 64.1 66.9 14.9 66.4 63.6 7.8 9.8 4Q19 1Q20 2Q20 3Q20 4Q20 Current debt Non-current debt Cash & Equi
Slide 12: Main Corporate Entities
Main Corporate Entities 55% Bioceres LLC 38,7M Bioceres Crop (USA) Outstanding shares Solutions Corp (NYSE: BIOX) (BIOX) 45% Public investors and others 9 international subsidiaries 100% 80% Bioceres 100% Rizobacter SA Semilas SA (ARG) (ARG) 50% 50% 50% Trigall Verdeca LLC Synertech SA Genetics SA (
Slide 13: Contact us
Contact us Investor Relations Investorrelations@biocerescrops.com (54) 0341 4861100 Investors.biocerescrops.com 13
Bioceres Crop Solutions — Morgan Stanley Investor Conference 2020 on 6ix